Brief: Protara Therapeutics Q1 EPS USD -0.31
13/05/2026 13:00
May 13 (Reuters) - Protara Therapeutics Q1 operating expenses USD 19.629 million. Q1 net income USD -17.782 million Q1 income from operations USD -19.629 million
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses